Management of statin induced myopathy
[DOCX File]Heather n Folz, pharmD
https://info.5y1.org/management-of-statin-induced-myopathy_1_66ea91.html
Statin-induced autoimmune myositis remains a rare (and likely new) subset of the statin-induced myopathy spectrum. As such, presentation, response to treatment and long-term prognosis remain incompletely defined and the evidence base for best- practice treatment is lacking.
[DOC File]Heather Kelly-Nix, PharmD
https://info.5y1.org/management-of-statin-induced-myopathy_1_658d65.html
3. Myopathy. can be caused by corticosteroids, or by antihyperlipidemics i.e. “statin” drugs. 4. Corticosteroids . used for many systems: pulmonary, rheumatology, dermatology, etc. suppression of the body’s immune response may be the therapeutic intent (post organ transplant, rheumatologic disease), or it may be an adverse effect
[DOCX File]Title: Statin Induced Autoimmune Myopathy
https://info.5y1.org/management-of-statin-induced-myopathy_1_0a478f.html
Consider choosing atorvastatin or rosuvastatin for their triglyceride-lowering-benefits. May require higher dose statin, addition of fibrate or Omega 3 fatty acid. Baseline labs: AST/ALT, TSH/fT4. (Untreated hypothyroidism may cause hyperlipidemia and can predispose to statin-induced myopathy.) Discuss lifestyle and consider . dietitian ...
University of Colorado Denver
Vitamin D Levels and Statin-induced Myopathy: A Retrospective Analysis. Eric Wombwell. 2008-2009. Impact of Contrast-Induced Nephropathy on In-Hospital Mortality and Need For Dialysis: A Review of Prophylactic Measures. Allyce Schenk. 2009-2010. Metabolic Syndrome Clinic …
[DOC File]University of Missouri
https://info.5y1.org/management-of-statin-induced-myopathy_1_61ca97.html
A fasting lipid profile should be performed prior to initiation of therapy and at 6-8 weeks after initiation or dose escalation to evaluate efficacy. Baseline levels of CPK are not necessary unless the patient is at risk for myopathy (e.g. renal or hepatic dysfunction; concomitant drug interaction that inhibits statin metabolism, etc.).
Managing Statin Myopathy - ScienceDirect
However, the absolute risk of myopathy with lipid-lowering agents (statin and fibrates) is small. In summary, data from large controlled trials, head to head fibrate trials, manufacturers prescribing information or other data do not support a difference in the rate of serious adverse events between gemfibrozil and fenofibrate when used as ...
[DOC File]Pharmacy Benefits Management Services Home
https://info.5y1.org/management-of-statin-induced-myopathy_1_eeaab2.html
Any statin dose can reduce cardiovascular risk. If a person cannot tolerate a high-dose statin, aim to treat with the maximum tolerated dose or consider changing to an alternative agent. Consider stopping the statin and, when the symptoms have resolved, re-challenge to check if the symptoms are indeed related to statin therapy.
[DOCX File]Cardiovascular Disease Risk Assessment and Management for ...
https://info.5y1.org/management-of-statin-induced-myopathy_1_8067c2.html
Sertraline Induced Myopathy in An Elderly Patient. Poster No. 41. Mohammad. Hamza. MBBS. ... A Case of Statin-Induced Necrotizing Autoimmune Myopathy. Poster No. 51. Tatyana. Joab. MD. Resident/Fellow Clinical Vignette. ... Nivolumab Induced Combined ACTH and GH Deficiency: A rare, life-threatening but easily correctable adverse event ...
[DOCX File]Poster Presenter Directory
https://info.5y1.org/management-of-statin-induced-myopathy_1_ba4025.html
The combination of TARCEVA and a statin may increase the potential for statin-induced myopathy, including rhabdomyolysis, which was observed rarely. In a Phase Ib study, there were no significant effects of gemcitabine on the pharmacokinetics of TARCEVA nor were there significant effects of TARCEVA on the pharmacokinetics of gemcitabine.
[DOC File]STATIN-FIBRATE REPORT: Focus on Safety
https://info.5y1.org/management-of-statin-induced-myopathy_1_b26651.html
The medical resident asks your advice on how to address this possible statin induced myopathy. Consider checking CK. Hold statin for 2-4 weeks. Check renal and hepatic function. Evaluate other possible causes. Once symptoms resolve, options include. Restart with same statin at same or lower dose. If symptoms return – d/c statin and start different statin at lower dose once symptoms resolve
Nearby & related entries:
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.